Gilead Lancaster, MD
Director, Non-Invasive Cardiology, Cardiovascular MedicineAbout
Titles
Director, Non-Invasive Cardiology, Cardiovascular Medicine; Associate Director, Cardiovascular Fellowship Program, Cardiovascular Medicine; Chairman, CPR Subcommittee, Cardiovascular Medicine
Appointments
Cardiovascular Medicine
Associate Clinical ProfessorPrimary
Other Departments & Organizations
Education & Training
- Felllow
- St. Luke’s Roosevelt Hospital Center, (1988)
- Resident
- St. Luke’s Roosevelt Hospital Center (1986)
- Intern
- SUNY Buffalo Affiliated Hospitals (1984)
- MD
- School of Medicine/Tel Aviv University (1983)
- BA
- Columbia College (1979)
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Gilead Lancaster's published research.
Publications Timeline
A big-picture view of Gilead Lancaster's research output by year.
Stuart Zarich, MD
Sun-Joo Jang, MD, PhD
2Publications
Publications
2024
In-Hospital Outcomes and 30-Day Readmission Rate After Transcatheter and Surgical Aortic Valve Replacement in Liver Cirrhosis: A Contemporary Propensity-Matched Analysis
Aggarwal A, Jang S, Vardhan S, Webber F, Alam M, Vardhan M, Lancaster G, Ahmad Y, Vora A, Zarich S, Inglessis-Azuaje I, Elmariah S, Forrest J, Davila C. In-Hospital Outcomes and 30-Day Readmission Rate After Transcatheter and Surgical Aortic Valve Replacement in Liver Cirrhosis: A Contemporary Propensity-Matched Analysis. Structural Heart 2024, 100327. DOI: 10.1016/j.shj.2024.100327.Peer-Reviewed Original ResearchConceptsSurgical aortic valve replacementTranscatheter aortic valve replacementAortic valve replacementTranscatheter aortic valve replacement groupValve replacementIn-hospital mortalityHepatorenal syndromeReadmission ratesCardiogenic shockLiver cirrhosisVascular complicationsIn-hospitalOutcomes of transcatheter aortic valve replacementSurgical risk prediction modelsSurgical aortic valve replacement groupAssociated with significantly lower ratesRates of in-hospital mortalityLimited contemporary dataIn-hospital outcomesSignificantly lower ratesNationwide Readmissions DatabaseCardiac surgeryPeriprocedural morbidityTherapeutic optionsClinical characteristics
2006
16.30 A novel index of ST elevation in lead aVR as a predictor of myocardial viability using exercise SPECT myocardial perfusion scintigraphy
Afaq M, Adigopula S, Blendea D, Upadhyay S, Lancaster G. 16.30 A novel index of ST elevation in lead aVR as a predictor of myocardial viability using exercise SPECT myocardial perfusion scintigraphy. Journal Of Nuclear Cardiology 2006, 13: s21. DOI: 10.1016/j.nuclcard.2006.06.069.Peer-Reviewed Original Research
Links & Media
News
- February 14, 2024
Yale Faculty Honored at Inaugural Voluntary Faculty Awards